Triple-negative breast cancer (TNBC) comprises 15% of all breast cancers and is characterized by the absence of expression of estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2). The gene discussed is PGR; the disease is triple-negative breast carcinoma.